Panitumumab is a monoclonal antibody which targets a certain type of protein on the surface of cancer cells to control their growth.
Please alert the nurse if you experience any of the following symptoms during infusion:
Other possible side effects
Inform your doctor if any of the following occurs:
Subscribe to our mailing list to get the updates to your email inbox...
SHP-Head Office, 167 Jalan Bukit Merah Connection One (Tower 5), #15-10, Singapore 150167+65 6236 4800